A carregar...
Polo-like kinase 4 inhibition:astrategy for cancer therapy?
In this issue of Cancer Cell, Mason et al. describe development of a Polo-like kinase 4 (Plk4) inhibitor (CFI-400945) with promising activity against tumors formed in mice from patient-derived tumor tissue. A clinical trial has initiated, but questions remain over whether Plk4 is the only relevant t...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4148003/ https://ncbi.nlm.nih.gov/pubmed/25117704 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2014.07.017 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|